COMMUNIQUÉS West-GlobeNewswire

Equillium to Present at Leerink Partners Global Healthcare Conference

21/02/2019 - 22:07

LA JOLLA, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immune-inflammatory disorders, announced today that Bruce Steel, Equillium’s [...]

Synthorx to Present at the 8th Annual SVB Leerink Global Healthcare Conference

21/02/2019 - 22:05

SAN DIEGO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for [...]

Calithera Biosciences Initiates Phase 1 Trial of Arginase Inhibitor CB-280 for the Treatment of Cystic Fibrosis

21/02/2019 - 22:05

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the [...]

Emergent BioSolutions Reports Fourth Quarter and Full Year 2018 Financial Results

21/02/2019 - 22:05

GAITHERSBURG, Md., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter and year ended December 31, 2018. FINANCIAL HIGHLIGHTS (in millions) Q4 2018 ( [...]

Opiant Pharmaceuticals Announces Top-line Results from Phase 2 Clinical Trial of OPNT001 for Treatment of Bulimia Nervosa

21/02/2019 - 22:05

-Study did not meet primary endpoint- -Company discontinuing development of OPNT001 for treatment of Bulimia Nervosa- -Focus remains on advancing lead product candidate, OPNT003, for treatment of opioid overdose, and [...]

HTG Molecular Diagnostics to Announce Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results and Host Conference Call on Thursday, March 7

21/02/2019 - 22:05

TUCSON, Ariz., Feb. 21, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial [...]

SI-BONE To Report Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019

21/02/2019 - 22:05

SANTA CLARA, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that is pioneering the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant [...]

BioTelemetry, Inc. Reports Fourth Quarter 2018 Financial Results

21/02/2019 - 22:05

Delivered Best Performance in Company’s History Exceeded Expectations MALVERN, Pa., Feb. 21, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the [...]

Assertio Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results After The Close of Markets on Wednesday, March 6, 2019

21/02/2019 - 22:05

LAKE FOREST, Ill., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release fourth quarter and full year 2018 financial results on Wednesday, March 6, 2019, after [...]

GenMark Diagnostics Reports Fourth Quarter and Full Year 2018 Results

21/02/2019 - 22:05

CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]

TRACON to Report Fourth Quarter and Full Year 2018 Company Highlights and Financial Results on February 28, 2019

21/02/2019 - 22:03

SAN DIEGO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

GenMark Diagnostics Announces Expansion of Executive Leadership Team

21/02/2019 - 22:03

CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the expansion of its [...]

Firmly on our way to becoming a fully integrated biopharma company

21/02/2019 - 22:02

Revenues doubled in 2018 Key 2018 clinical results: FINCH 2 Phase 3 trial with filgotinib in rheumatoid arthritis (RA) met all primary and secondary endpoints, with consistent tolerability TORTUGA and EQUATOR Phase 2 [...]

Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2018 Corporate Update and Results

21/02/2019 - 22:02

CAMBRIDGE, Mass., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Thursday, February 28, 2019 [...]

Dermira to Present at the 8th Annual SVB Leerink Global Healthcare Conference

21/02/2019 - 22:01

MENLO PARK, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]

Allscripts announces fourth quarter and 2018 full-year results

21/02/2019 - 22:01

Record fourth quarter bookings of $531 million up 69% from the prior year period Fourth quarter GAAP diluted EPS of $2.14; growth of 11% in non-GAAP diluted EPS to $0.20 Full year 2018 GAAP diluted EPS of $2.04; growth [...]

Cytokinetics Reports Fourth Quarter 2018 Financial Results

21/02/2019 - 22:00

Company Provides 2019 Financial Guidance and Expected Milestones Reduced Operating Expenses vs. 2018; Over Two Years of Cash Based on Current Burn Rate Interim Analysis for GALACTIC-HF on Track for 1H 2019 Results from [...]

Trillium Announces Proposed Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units

21/02/2019 - 22:00

TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of [...]

Exactus to Attend 15th Annual PDS Super Conference

21/02/2019 - 21:13

Largest Gathering of Independent Pharmacy Owners in US GLEN ALLEN, Va., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) , a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) [...]